![Tonix Pharmaceuticals Holding Corporation](/common/images/company/N_TNXP.png)
Tonix Pharmaceuticals Holding Corporation (TNXP)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 3.99M | 3.78M | 2.48M |
Operating Income | -23.34M | -29.59M | -32.73M | -33.9M | -29M | -28.15M | -27.33M | -21.35M |
Pre Tax Income | -23.14M | -28.98M | -31.68M | -33.01M | -28.36M | -27.98M | -27.32M | -14.94M |
Net Income | -27.4M | -28.98M | -34.08M | -33.01M | -28.36M | -27.98M | -27.32M | -14.94M |
Preferred Dividends | -4.26M | 0 | -2.4M | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -23.34M | -29.59M | -32.73M | -33.9M | -29M | -28.15M | -25.61M | -21.94M |
EBITDA | -23.23M | -29.34M | -31.89M | -33.01M | -28.08M | -26.93M | -26.07M | -20.14M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.77M |
Operating Income | -38.97M | -21.29M | -26.32M | -28.83M | -50.51M | -92.31M | -112.09M | -118.38M |
Pre Tax Income | -38.84M | -21.12M | -26.09M | -28.62M | -50.46M | -92.29M | -110.22M | -116.66M |
Net Income | -38.84M | -21.12M | -29.36M | -31.09M | -52.17M | -92.29M | -116.88M | -116.66M |
Preferred Dividends | 0 | 0 | -3.27M | -2.47M | -1.26M | 0 | -6.66M | 0 |
Basic Earnings Per Share (EPS) | -0.991 | -2.698 | -8.999 | -3.644 | -0.253 | -0.186 | -1.208 | -4.345 |
EBIT | -38.97M | -21.29M | -26.32M | -28.83M | -50.51M | -92.31M | -112.09M | -116.66M |
EBITDA | -38.84M | -21.22M | -26.27M | -28.8M | -50.48M | -92.26M | -110.84M | -114.09M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.